Related Experiment Videos
Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice
1Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
Immunological Reviews
|August 18, 1999
Summary
CD1d molecules present lipids to natural killer T cells, which are crucial for immune responses. CD1d-dependent T cells and alpha-galactosylceramide show therapeutic potential in diseases.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- CD1 molecules are antigen-presenting molecules related to MHC, binding lipids instead of peptides.
- CD1d molecules present glycolipid antigens like alpha-galactosylceramide (alpha-GalCer) to CD1d-restricted natural killer (NK) T cells.
Purpose of the Study:
- To investigate the role of CD1d expression in NK T cell development and function.
- To evaluate the therapeutic potential of alpha-GalCer in disease models.
Main Methods:
- Utilized CD1d knockout mice to study NK T cell development and responses.
- Administered alpha-GalCer to wild-type and CD1d mutant mice, and assessed tumor clearance and disease inhibition.
Main Results:
- CD1d expression is essential for NK T cell development and rapid cytokine production (IL-4, IFN-gamma) upon anti-CD3 stimulation.
- CD1d knockout mice showed impaired responses to alpha-GalCer stimulation.
- Alpha-GalCer administration cleared metastatic tumors in wild-type mice and inhibited disease in non-obese diabetic mice.
Conclusions:
- CD1d-dependent T cells play a critical role in various disease conditions.
- Alpha-Galactosylceramide demonstrates therapeutic potential for diseases involving CD1d-dependent immune responses.